Rucaparib received FDA approval for BRCA-mutated mCRPC after prior androgen receptor–directed therapy, based on the TRITON3 trial results. The trial demonstrated significant improvement in ...
It is time for Infantry leaders and Soldiers to fully embrace the Modern Army Combatives Program (MACP). Few programs, if any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback